Elucidating pharmacodynamic interaction of silver nanoparticle - topical deliverable antibiotics

In order to exploit the potential benefits of antimicrobial combination therapy, we need a better understanding of the circumstances under which pharmacodynamic interactions expected. In this study, Pharmacodynamic interactions between silver nanoparticle (SNP) and topical antibiotics such as Cefazo...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 6; no. 1; p. 29982
Main Authors Thirumurugan, G, Seshagiri Rao, J V L N, Dhanaraju, M D
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 18.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In order to exploit the potential benefits of antimicrobial combination therapy, we need a better understanding of the circumstances under which pharmacodynamic interactions expected. In this study, Pharmacodynamic interactions between silver nanoparticle (SNP) and topical antibiotics such as Cefazolin (CEF), Mupirocin (MUP), Gentamycin (GEN), Neomycin (NEO), Tetracycline (TET), Vancomycin (VAN) were investigated using the MIC test, Combination assay followed by Fractional Inhibitory concentration Index and Agar well diffusion method. SNP + MUP, SNP + NEO, SNP + VAN combinations showed Synergism (SN) and SNP + CEF, SNP + GEN, SNP + TET showed Partial synergism (PS) against Staphylococcus aureus. Four combinations (SNP + CEF, SNP + MUP, SNP + GEN, SNP + VAN) showed SN, SNP + TET showed PS and Indifferent effect (ID) were observed for SNP + NEO against Pseudomonas aeruginosa. SN was observed for SNP + CEF, SNP + GEN, SNP + NEO, SNP + TET and SNP + MUP showed ID, SNP + VAN showed PS against Escherichia coli. In addition, we elucidated the possible mechanism involved in the pharmacodynamic interaction between SNP-topical antibiotics by increased ROS level, membrane damage following protein release, K(+) leakage and biofilm inhibition. Thus, our findings support that conjugation of the SNP with topical antibiotics have great potential in the topical formulation when treating complex resistant bacterial infections and where there is a need of more concentration to kill pathogenic bacteria.
AbstractList In order to exploit the potential benefits of antimicrobial combination therapy, we need a better understanding of the circumstances under which pharmacodynamic interactions expected. In this study, Pharmacodynamic interactions between silver nanoparticle (SNP) and topical antibiotics such as Cefazolin (CEF), Mupirocin (MUP), Gentamycin (GEN), Neomycin (NEO), Tetracycline (TET), Vancomycin (VAN) were investigated using the MIC test, Combination assay followed by Fractional Inhibitory concentration Index and Agar well diffusion method. SNP + MUP, SNP + NEO, SNP + VAN combinations showed Synergism (SN) and SNP + CEF, SNP + GEN, SNP + TET showed Partial synergism (PS) against Staphylococcus aureus . Four combinations (SNP + CEF, SNP + MUP, SNP + GEN, SNP + VAN) showed SN, SNP + TET showed PS and Indifferent effect (ID) were observed for SNP + NEO against Pseudomonas aeruginosa . SN was observed for SNP + CEF, SNP + GEN, SNP + NEO, SNP + TET and SNP + MUP showed ID, SNP + VAN showed PS against Escherichia coli . In addition, we elucidated the possible mechanism involved in the pharmacodynamic interaction between SNP-topical antibiotics by increased ROS level, membrane damage following protein release, K + leakage and biofilm inhibition. Thus, our findings support that conjugation of the SNP with topical antibiotics have great potential in the topical formulation when treating complex resistant bacterial infections and where there is a need of more concentration to kill pathogenic bacteria.
In order to exploit the potential benefits of antimicrobial combination therapy, we need a better understanding of the circumstances under which pharmacodynamic interactions expected. In this study, Pharmacodynamic interactions between silver nanoparticle (SNP) and topical antibiotics such as Cefazolin (CEF), Mupirocin (MUP), Gentamycin (GEN), Neomycin (NEO), Tetracycline (TET), Vancomycin (VAN) were investigated using the MIC test, Combination assay followed by Fractional Inhibitory concentration Index and Agar well diffusion method. SNP + MUP, SNP + NEO, SNP + VAN combinations showed Synergism (SN) and SNP + CEF, SNP + GEN, SNP + TET showed Partial synergism (PS) against Staphylococcus aureus. Four combinations (SNP + CEF, SNP + MUP, SNP + GEN, SNP + VAN) showed SN, SNP + TET showed PS and Indifferent effect (ID) were observed for SNP + NEO against Pseudomonas aeruginosa. SN was observed for SNP + CEF, SNP + GEN, SNP + NEO, SNP + TET and SNP + MUP showed ID, SNP + VAN showed PS against Escherichia coli. In addition, we elucidated the possible mechanism involved in the pharmacodynamic interaction between SNP-topical antibiotics by increased ROS level, membrane damage following protein release, K(+) leakage and biofilm inhibition. Thus, our findings support that conjugation of the SNP with topical antibiotics have great potential in the topical formulation when treating complex resistant bacterial infections and where there is a need of more concentration to kill pathogenic bacteria.
Abstract In order to exploit the potential benefits of antimicrobial combination therapy, we need a better understanding of the circumstances under which pharmacodynamic interactions expected. In this study, Pharmacodynamic interactions between silver nanoparticle (SNP) and topical antibiotics such as Cefazolin (CEF), Mupirocin (MUP), Gentamycin (GEN), Neomycin (NEO), Tetracycline (TET), Vancomycin (VAN) were investigated using the MIC test, Combination assay followed by Fractional Inhibitory concentration Index and Agar well diffusion method. SNP + MUP, SNP + NEO, SNP + VAN combinations showed Synergism (SN) and SNP + CEF, SNP + GEN, SNP + TET showed Partial synergism (PS) against Staphylococcus aureus . Four combinations (SNP + CEF, SNP + MUP, SNP + GEN, SNP + VAN) showed SN, SNP + TET showed PS and Indifferent effect (ID) were observed for SNP + NEO against Pseudomonas aeruginosa . SN was observed for SNP + CEF, SNP + GEN, SNP + NEO, SNP + TET and SNP + MUP showed ID, SNP + VAN showed PS against Escherichia coli . In addition, we elucidated the possible mechanism involved in the pharmacodynamic interaction between SNP-topical antibiotics by increased ROS level, membrane damage following protein release, K + leakage and biofilm inhibition. Thus, our findings support that conjugation of the SNP with topical antibiotics have great potential in the topical formulation when treating complex resistant bacterial infections and where there is a need of more concentration to kill pathogenic bacteria.
ArticleNumber 29982
Author Seshagiri Rao, J V L N
Dhanaraju, M D
Thirumurugan, G
Author_xml – sequence: 1
  givenname: G
  surname: Thirumurugan
  fullname: Thirumurugan, G
  organization: Research Lab, GIET School of Pharmacy, Chaitanya Nagar, Rajahmundry, AP, India
– sequence: 2
  givenname: J V L N
  surname: Seshagiri Rao
  fullname: Seshagiri Rao, J V L N
  organization: Department of Pharmaceutical analysis, AU College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, AP, India
– sequence: 3
  givenname: M D
  surname: Dhanaraju
  fullname: Dhanaraju, M D
  organization: Research Lab, GIET School of Pharmacy, Chaitanya Nagar, Rajahmundry, AP, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27427207$$D View this record in MEDLINE/PubMed
BookMark eNpVkUtLAzEQx4NUbK09-AVkwZOH1c1jXxdBSn1AwYue42webco2WbNpod_eSGupc5lh5sd_hv9cooF1ViF0jbN7nNHqofeqI3VdkTM0IhnLU0IJGZzUQzTp-1UWIyc1w_UFGpKSkZJk5Qh9zdqNMBKCsYukW4Jfg3ByZ2FtRGJsUB5EMM4mTie9abfKJxas68AHI1qVpElwnRHQJlK1Jo6hiV2wwTTGRaS_Quca2l5NDnmMPp9nH9PXdP7-8jZ9mqeCZTSkNKNSFzmQmmIioQGQhBRCN2UDZaVxXqiqUUxqXWCNGRQgZUFlzhgjuNAVHaPHvW63adZKCmWDh5Z33qzB77gDw_9PrFnyhdtyVrOyzmkUuD0IePe9UX3gK7fxNt7McYXLqspZTSJ1t6eEd320Xh834Iz__oMf_xHZm9OTjuSf-_QHUfSLSg
CitedBy_id crossref_primary_10_3390_coatings11040388
crossref_primary_10_1021_acsomega_8b00637
crossref_primary_10_1080_10934529_2018_1558892
crossref_primary_10_3390_pharmaceutics14102235
crossref_primary_10_1021_acsanm_2c05526
crossref_primary_10_1016_j_cej_2019_122582
crossref_primary_10_1038_s41429_018_0111_6
crossref_primary_10_3390_pharmaceutics14071519
crossref_primary_10_1016_j_pathol_2021_08_014
crossref_primary_10_1039_C8TB00907D
crossref_primary_10_1039_D0CC05880G
crossref_primary_10_1016_j_mssp_2019_05_007
crossref_primary_10_1007_s12010_023_04592_w
crossref_primary_10_1016_j_colsurfb_2024_113826
crossref_primary_10_1016_j_jddst_2023_104897
crossref_primary_10_1021_acsabm_3c00051
crossref_primary_10_3233_MGC_210131
crossref_primary_10_22207_JPAM_16_3_13
crossref_primary_10_1016_j_mtcomm_2020_101574
crossref_primary_10_1016_j_jconrel_2019_06_013
crossref_primary_10_1208_s12249_022_02381_y
crossref_primary_10_3390_antibiotics12081264
crossref_primary_10_1016_j_foodcont_2020_107148
crossref_primary_10_3390_antibiotics12121690
crossref_primary_10_1007_s13205_018_1436_3
crossref_primary_10_1021_acsami_7b10384
crossref_primary_10_3390_molecules22081370
Cites_doi 10.1016/j.nano.2006.12.001
10.1099/mic.0.022731-0
10.1111/jphs.12095
10.1166/jbn.2011.1336
10.3389/fmicb.2013.00353
10.1099/jmm.0.047100-0
10.1016/j.nano.2009.04.006
10.1586/14787210.2013.846215
10.1088/0957-4484/18/22/225103
10.1074/jbc.274.31.21953
10.1016/S0168-6445(03)00047-0
10.1128/AAC.01106-08
10.1007/s11051-008-9428-6
10.1074/jbc.M406044200
10.1093/jac/dkg301
10.1016/j.actbio.2007.11.006
10.1016/j.cell.2007.06.049
ContentType Journal Article
Copyright Copyright Nature Publishing Group Jul 2016
Copyright © 2016, Macmillan Publishers Limited 2016 Macmillan Publishers Limited
Copyright_xml – notice: Copyright Nature Publishing Group Jul 2016
– notice: Copyright © 2016, Macmillan Publishers Limited 2016 Macmillan Publishers Limited
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
5PM
DOI 10.1038/srep29982
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Medical Database
ProQuest Science Journals
Biological Science Database
Publicly Available Content (ProQuest)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList
MEDLINE
Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID 4175907121
10_1038_srep29982
27427207
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
CGR
CUY
CVF
DIK
DWQXO
EBD
EBLON
EBS
ECM
EIF
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
NPM
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AAYXX
AFPKN
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
5PM
ID FETCH-LOGICAL-c403t-303df65a29312dabaad226cfb7ba78f156e8be4dff61f14a6add63d5444216f83
IEDL.DBID RPM
ISSN 2045-2322
IngestDate Tue Sep 17 21:27:07 EDT 2024
Fri Sep 13 08:11:12 EDT 2024
Fri Aug 23 02:54:36 EDT 2024
Wed Oct 09 10:27:28 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c403t-303df65a29312dabaad226cfb7ba78f156e8be4dff61f14a6add63d5444216f83
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947953/
PMID 27427207
PQID 1817885492
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4947953
proquest_journals_1817885492
crossref_primary_10_1038_srep29982
pubmed_primary_27427207
PublicationCentury 2000
PublicationDate 2016-07-18
PublicationDateYYYYMMDD 2016-07-18
PublicationDate_xml – month: 07
  year: 2016
  text: 2016-07-18
  day: 18
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Scientific reports
PublicationTitleAlternate Sci Rep
PublicationYear 2016
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References GA Martínez-Castañón (BFsrep29982_CR5) 2008; 10
DK Tiwari (BFsrep29982_CR15) 2008; 95
JS Kim (BFsrep29982_CR4) 2007; 3
F Guilhelmelli (BFsrep29982_CR16) 2013; 4
S Silver (BFsrep29982_CR3) 2003; 27
S Shrivastava (BFsrep29982_CR7) 2007; 18
FC Odds (BFsrep29982_CR19) 2003; 52
BFsrep29982_CR14
BFsrep29982_CR1
BFsrep29982_CR17
R Serge (BFsrep29982_CR10) 2009; 53
BFsrep29982_CR18
G Thirumurugan (BFsrep29982_CR20) 2015; 6
JG Kmeid (BFsrep29982_CR2) 2013; 11
RB Raja (BFsrep29982_CR11) 2013; 2
JP Ruparelia (BFsrep29982_CR8) 2008; 4
AM Fayaz (BFsrep29982_CR9) 2010; 6
BD Dill (BFsrep29982_CR21) 2009; 155
MA Kohanski (BFsrep29982_CR12) 2007; 130
In-sok Hwang. (BFsrep29982_CR13) 2012; 61
G Thirumurugan (BFsrep29982_CR6) 2011; 7
References_xml – volume: 3
  start-page: 95
  year: 2007
  ident: BFsrep29982_CR4
  publication-title: Nanomed. Nanotechnol. Biol. Med.
  doi: 10.1016/j.nano.2006.12.001
  contributor:
    fullname: JS Kim
– volume: 155
  start-page: 210
  year: 2009
  ident: BFsrep29982_CR21
  publication-title: Microbiology
  doi: 10.1099/mic.0.022731-0
  contributor:
    fullname: BD Dill
– ident: BFsrep29982_CR1
– volume: 6
  start-page: 97
  year: 2015
  ident: BFsrep29982_CR20
  publication-title: Journal of Pharmaceutical Health Services Research
  doi: 10.1111/jphs.12095
  contributor:
    fullname: G Thirumurugan
– volume: 7
  start-page: 659
  year: 2011
  ident: BFsrep29982_CR6
  publication-title: J. Biomed. Nanotechnol
  doi: 10.1166/jbn.2011.1336
  contributor:
    fullname: G Thirumurugan
– volume: 4
  start-page: 353
  year: 2013
  ident: BFsrep29982_CR16
  publication-title: Frontiers in Microbiology
  doi: 10.3389/fmicb.2013.00353
  contributor:
    fullname: F Guilhelmelli
– ident: BFsrep29982_CR18
– volume: 61
  start-page: 1719
  year: 2012
  ident: BFsrep29982_CR13
  publication-title: J. Med. Microbiol
  doi: 10.1099/jmm.0.047100-0
  contributor:
    fullname: In-sok Hwang.
– volume: 6
  start-page: 103
  year: 2010
  ident: BFsrep29982_CR9
  publication-title: Nanomedicine: Nanotechnology, Biology and Medicine
  doi: 10.1016/j.nano.2009.04.006
  contributor:
    fullname: AM Fayaz
– volume: 11
  start-page: 1355
  year: 2013
  ident: BFsrep29982_CR2
  publication-title: Expert Rev Anti Infect Ther.
  doi: 10.1586/14787210.2013.846215
  contributor:
    fullname: JG Kmeid
– volume: 18
  start-page: 225103
  year: 2007
  ident: BFsrep29982_CR7
  publication-title: Nanotechnology
  doi: 10.1088/0957-4484/18/22/225103
  contributor:
    fullname: S Shrivastava
– ident: BFsrep29982_CR14
  doi: 10.1074/jbc.274.31.21953
– volume: 27
  start-page: 341
  year: 2003
  ident: BFsrep29982_CR3
  publication-title: FEMS Microbiol. Rev.
  doi: 10.1016/S0168-6445(03)00047-0
  contributor:
    fullname: S Silver
– volume: 53
  start-page: 3538
  year: 2009
  ident: BFsrep29982_CR10
  publication-title: Antimicrob. Agents Chemother
  doi: 10.1128/AAC.01106-08
  contributor:
    fullname: R Serge
– volume: 10
  start-page: 1343
  year: 2008
  ident: BFsrep29982_CR5
  publication-title: J Nanoparticle Res.
  doi: 10.1007/s11051-008-9428-6
  contributor:
    fullname: GA Martínez-Castañón
– volume: 2
  start-page: 1
  year: 2013
  ident: BFsrep29982_CR11
  publication-title: Bioresearch Bulletin
  contributor:
    fullname: RB Raja
– ident: BFsrep29982_CR17
  doi: 10.1074/jbc.M406044200
– volume: 52
  start-page: 1
  year: 2003
  ident: BFsrep29982_CR19
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkg301
  contributor:
    fullname: FC Odds
– volume: 4
  start-page: 707
  year: 2008
  ident: BFsrep29982_CR8
  publication-title: Acta Biomater
  doi: 10.1016/j.actbio.2007.11.006
  contributor:
    fullname: JP Ruparelia
– volume: 95
  start-page: 647
  year: 2008
  ident: BFsrep29982_CR15
  publication-title: Curr Sci.
  contributor:
    fullname: DK Tiwari
– volume: 130
  start-page: 797
  year: 2007
  ident: BFsrep29982_CR12
  publication-title: Cell
  doi: 10.1016/j.cell.2007.06.049
  contributor:
    fullname: MA Kohanski
SSID ssj0000529419
Score 2.3725553
Snippet In order to exploit the potential benefits of antimicrobial combination therapy, we need a better understanding of the circumstances under which...
Abstract In order to exploit the potential benefits of antimicrobial combination therapy, we need a better understanding of the circumstances under which...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 29982
SubjectTerms Administration, Topical
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - pharmacology
Antibiotics
Antimicrobial agents
Bacterial infections
Biofilms - drug effects
Drugs
E coli
Electrophoresis, Polyacrylamide Gel
Escherichia coli - drug effects
Escherichia coli - physiology
Metal Nanoparticles - administration & dosage
Microbial Sensitivity Tests
Microbial Viability - drug effects
Nanoparticles
Pharmaceutical sciences
Pharmacodynamics
Potassium - metabolism
Pseudomonas aeruginosa - drug effects
Pseudomonas aeruginosa - physiology
Reactive Oxygen Species - metabolism
Silver
Silver - administration & dosage
Silver - pharmacology
Staphylococcus aureus - drug effects
Staphylococcus aureus - physiology
Wound healing
SummonAdditionalLinks – databaseName: Health & Medical Collection (Proquest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA4-ELyIb9cXQbyG3TZpkp5ERFkEPSnsrebRaEHautaD_96Zbbu6Cp5bUphJZ755fUPIOcSxEmCHZcHymIl8pJk2xjKPGUjnLVccB4Xv7uX4UdxOkskSGfezMNhW2dvEmaH2lcMc-RA8EURryCc2NBazAK4ZXtRvDPdHYZ21W6axTFajGGAF3Gw1UfNsC9azRJT21EJcD8EB1WCKdbzokP6gzN_Nkj-8z80m2ehgI71s9bxFlvJym6y1iyQ_d8jT9euHK3BSoXymdcdG7dtl8xQZIabt_AKtAn0vsBmalqaEeLk9jzLaVDWqi_r8FTs1cKCKgtALW1RI5LxLHm-uH67GrNudwJwY8YaBZ_JBJga8eRR7Y43xALRcsMoapQNEbbm2ufAhyChEwkiwc5L7RAgRRzJovkdWyqrMDwi1KaCqRDptgsfwJtUi5NKNgndRcCM1IGe9ALO6pcjIZqVtrrO5lAfkuBdt1v0l79m3Tgdkv5Xy_AQsIasYT1cL8p-_gLzYi0_K4mXGjy1SodKEH_7_ySOyDuBHYp420sdkpZl-5CcAMBp7Ors7X6GD1o0
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8QwEA6iCF7Et-uLIF6jbZOm6UFERBFBTy7srSZNo4Wlu-4D3H_vTNMuu-rBc9tQvklmvkky3xByAXmsBNphmDM8YqIIFFNaG2ZxBzK3hiccC4WfX-RjVzz14t4KaXtsNgCO_0ztsJ9Ud9S__Pqc3cCCv_Yl4-oKYskQvKoCT7wWCS5woj83LN9LfEepqFt8oPY6Aw4RtRpDi18vR6ZfdPPnrcmFMPSwRTYb_khvvcG3yUpR7ZB131Fytkve7vvTvMSSheqdDhtZauu7zlOUhhj5QgY6cHRc4q1oWukKEmc_HmV0Mhii3agt-nhlAyurKKBfmnKAis57pPtw_3r3yJomCiwXAZ8wCFHWyVhDWA8jq43WFhhX7kxidKIcpG-FMoWwzsnQhUJLcHiS21gIEYXSKb5PVqtBVRwSalKgV7HMlXYW85xUCVfIPHA2D10eJB1y3gKYDb1WRlafcXOVzVHukJMW2qy1dgY0A1JxFIvrkAOP8nwEPEtOIhw9WcJ__gIKZC8_qcqPWihbpCJJY370n_86JhvAhSRu24bqhKxORtPiFPjGxJzVs-kb6_nY3Q
  priority: 102
  providerName: Scholars Portal
Title Elucidating pharmacodynamic interaction of silver nanoparticle - topical deliverable antibiotics
URI https://www.ncbi.nlm.nih.gov/pubmed/27427207
https://www.proquest.com/docview/1817885492/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC4947953
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50RfAivl1dlyBe626bNEmPKisirIgo7K3m0Whh7RZdD_57J30sq9689NI2lMk0833JzDcAZ8hjOcIOHThNo4BlQxlIpXRg_Q6ksZoK6guFx3f85ondTuLJCsRtLUyVtG90fl5M386L_LXKrSzfzKDNExvcj69YwkQS08EqrApKlyh6LegdJSxMWhUhKgcYa0pcdaXvXONPJkXkm8cuh6E_2PJ3iuRSzLnegs0GLJKL-qO2YSUrdmC9bh_5tQvPo-mnyX19QvFCykaD2tYt5onXgXivqxbIzJGP3KdAk0IVyJLr8UhA5rPSTxKx2dTnZ_gyKoKmznU-8_LNe_B0PXq8ugmajgmBYUM6DzAeWcdjhTE8jKzSSlmEV8ZpoZWQDrlaJnXGrHM8dCFTHFc3Tm3MGItC7iTdh04xK7JDIDpBLBVzI5WzntQkkrmMm6GzJnRmKLpw2howLWthjLQ60KYyXRi8C73WtGnzb3ykiCmQd3tluC4c1FZejNBOTxfED_svHvBq2D_voJNUqtiNUxz9-81j2EA0xP3GbSh70Jm_f2YniDjmuo9-NhF9WLsc3d0_9Cvejtcxk_3K974BS0jgFw
link.rule.ids 230,315,733,786,790,870,891,12083,21416,24346,27957,27958,31754,33779,43345,43840,53827,53829,74102,74659
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9tAEB61QVW5oD4hQNsV4roi9q7X6xOCKijlESEEEjd3H16whGxDwoF_z0zsBFKknm2tpRnvzDevbwB2MY5VCDssD1bEXBYDzbUxlnvKQDpvRSpoUPhsrEZX8vg6ue4SbpOurXJuE2eG2teOcuR76IkwWiM-sf3mntPWKKqudis03sOKFBiq9GDlcDg-v1hkWaiOJaNsTikk9B46ngZNsI6XHdEbdPlvk-Qrr3P0CdY6uMgOWv1-hndF9QU-tAskn77C3-HdoytpQqG6YU3HQu3bJfOMmCAe2rkFVgc2KakJmlWmwji5PY9xNq0bUhPzxR11aNAgFUNhl7asicD5G1wdDS9_j3i3M4E7ORBTjh7JB5UY9OJR7I01xiPAcsGm1qQ6YLRWaFtIH4KKQiSNQvumhE-klHGkghbfoVfVVbEBzGaIphLltAmewppMy1AoNwjeRcEN0j7szAWYNy01Rj4raQudL6Tch-25aPPudkzyF132Yb2V8uIEKh2nMZ2eLsl_8QLxYS8_qcrbGS-2zGSaJWLz_5_8BR9Hl2en-emf8ckWrCIAUpSrjfQ29KYPj8UPBBlT-7P7k54BRj3XJg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9tAEF5REBWXqkCBlEdXiOsqtne9uz5VFSUKFBAHkHJz9-FtLUW2IcmBf89M7ISmSJxtraWZ9Xzz_IaQM4hjJbgdlgXLEyaKSDNtjGUeM5DOW644Dgrf3Mrhg7gapaOu_2nStVUubOLcUPvaYY68D0gE0RryifVD1xZx93PwvXlkuEEKK63dOo0PZANQMsJtBmqklvkWrGiJOFuQC3HdBwhqwBjrZBWS3viZ_7dL_oM_g8_kU-c40h-tprfJWlHtkM12leTzLvl9MZ65EmcVqj-06fiofbtuniInxFM7wUDrQCcltkPTylQQMbfnUUandYMKo74YY68GjlRREHtpyxqpnL-Qh8HF_fmQddsTmBMRnzLAJh9kagDP48Qba4wHV8sFq6xROkDcVmhbCB-CjEMsjARLJ7lPhRBJLIPme2S9qqvigFCbgV-VSqdN8BjgZFqEQrooeBcHF6keOV0IMG9akox8XtzmOl9KuUeOFqLNu_9kkr9qtUf2WykvT8AiskrwdLUi_-ULyIy9-qQq_84ZskUmVJbyr-9_8hv5CFcov768_XVItsATkpi0jfURWZ8-zYpj8Dam9mR-jV4AKy7Z7A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elucidating+pharmacodynamic+interaction+of+silver+nanoparticle+-+topical+deliverable+antibiotics&rft.jtitle=Scientific+reports&rft.au=Thirumurugan%2C+G.&rft.au=Seshagiri+Rao%2C+J.+V.+L.+N.&rft.au=Dhanaraju%2C+M.+D.&rft.date=2016-07-18&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=6&rft.issue=1&rft_id=info:doi/10.1038%2Fsrep29982&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_srep29982
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon